PGP is a multi-drug resistance (MDR) gene product, which acts as a drug pump to induce drug resistance in cancer cells, and is mainly used in the study of various malignant tumor (such as renal cell carcinoma, liver cancer, gastrointestinal cancer, breast cancer, etc.).